Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S V Rajkumar

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
Blood Cancer Journal|February 18, 2017
Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myelomaN Tandon, S V Rajkumar, B LaPlant, et al.
Leukemia|June 29, 2017
Natural history of t(11;14) multiple myelomaA Lakshman, M Alhaj Moustafa, S V Rajkumar, et al.
Leukemia|April 23, 2010
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and managementR A Kyle, B G M Durie, S V Rajkumar, et al.
Leukemia|July 21, 2006
International uniform response criteria for multiple myelomaB G M Durie, J-L Harousseau, J S Miguel, et al.
Leukemia|September 2, 2017
Pomalidomide-dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trialS Ailawadhi, J R Mikhael, B R LaPlant, et al.
Leukemia|November 21, 2008
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disordersA Dispenzieri, R Kyle, G Merlini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2016
Second primary malignancies in multiple myeloma: an overview and IMWG consensusP Musto, K C Anderson, M Attal, et al.
Leukemia|December 21, 2007
Prevention of thalidomide- and lenalidomide-associated thrombosis in myelomaA Palumbo, S V Rajkumar, M A Dimopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2017
Second primary malignancies in multiple myeloma: an overview and IMWG consensusP Musto, K C Anderson, M Attal, et al.
Leukemia|November 21, 2013
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)E M Ocio, P G Richardson, S V Rajkumar, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Blood Cancer Journal|February 18, 2017
Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myelomaN Tandon, S V Rajkumar, B LaPlant, et al.
Leukemia|June 29, 2017
Natural history of t(11;14) multiple myelomaA Lakshman, M Alhaj Moustafa, S V Rajkumar, et al.
Leukemia|April 23, 2010
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and managementR A Kyle, B G M Durie, S V Rajkumar, et al.
Leukemia|July 21, 2006
International uniform response criteria for multiple myelomaB G M Durie, J-L Harousseau, J S Miguel, et al.
Leukemia|September 2, 2017
Pomalidomide-dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trialS Ailawadhi, J R Mikhael, B R LaPlant, et al.
Leukemia|November 21, 2008
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disordersA Dispenzieri, R Kyle, G Merlini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2016
Second primary malignancies in multiple myeloma: an overview and IMWG consensusP Musto, K C Anderson, M Attal, et al.
Leukemia|December 21, 2007
Prevention of thalidomide- and lenalidomide-associated thrombosis in myelomaA Palumbo, S V Rajkumar, M A Dimopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2017
Second primary malignancies in multiple myeloma: an overview and IMWG consensusP Musto, K C Anderson, M Attal, et al.
Leukemia|November 21, 2013
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)E M Ocio, P G Richardson, S V Rajkumar, et al.
Pageof 18